Introduction: Immunoglobulin light chain (AL) amyloidosis is the most common type of amyloidosis, mainly affecting the heart, kidneys and central nervous system. Objective: To report a case of AL-form renal amyloidosis in a patient with initial clinical presentation of edemigenic syndrome. Case report: A 46-year-old man presented with generalized edema and dyspnea. An investigation began into the possible etiologies of edemigenic syndrome, in which renal etiology was the main hypothesis. Protein electrophoresis showed a peak in alpha 2 globulin and serum immunofixation with the presence of a monoclonal lambda band (light chain), then abdominal fat pad biopsy revealed amyloid deposits in the dermis and subcutaneous cellular tissue, confirming the hypothesis of primary amyloidosis with renal involvement. A renal biopsy was performed, which showed amyloid deposits in the glomerular compartment. Bortezomib was started, but there was a progressive worsening of renal function, leading to renal replacement therapy before starting the medication. Conclusion: AL amyloidosis is a progressive disease in which early diagnosis is essential to avoid irreversible losses of organ function.
No takes yet. Share an insight, caveat, or question.
Reis et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: